Polar Capital Global Healthcare Trust

PCGH:LSE

Polar Capital Global Healthcare Trust

Actions
  • Price (GBX)418.60
  • Today's Change2.60 / 0.63%
  • Shares traded85.18k
  • 1 Year change+13.75%
  • Beta0.5791
Data delayed at least 20 minutes, as of Feb 18 2026 12:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Polar Capital Global Healthcare Trust's revenues fell -- from 69.01m to -23.48m. has gone from a gain of 62.80m to a loss of 28.05m.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-5.95%
Return on equity-6.05%
Return on investment-6.05%
More ▼

Cash flow in GBPView more

In 2025, Polar Capital Global Healthcare Trust increased its cash reserves by 85.60%, or 7.86m. The company earned 10.80m from its operations for a Cash Flow Margin of -46.00%. In addition the company used on investing activities and also paid 2.94m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share3.70
Tangible book value per share3.70
More ▼

Balance sheet in GBPView more

Polar Capital Global Healthcare Trust has little financial risk as the capital structure does not rely on leverage.
Current ratio1.94
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in GBP

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -8.33% and -144.67%, respectively. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)0.66%
Div growth rate (5 year)1.92%
Payout ratio (TTM)--
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-144.67
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.